269 related articles for article (PubMed ID: 16432996)
1. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.
Bolukbas C; Bolukbas FF; Kebdir T; Canayaz L; Dalay AR; Kilic G; Ovunc O
Acta Gastroenterol Belg; 2005; 68(4):432-4. PubMed ID: 16432996
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonal sarcoidosis: A rare side effect of interferon-alpha treatment for chronic hepatitis C infection].
Pohl J; Stremmel W; Kallinowski B
Z Gastroenterol; 2000 Dec; 38(12):951-5. PubMed ID: 11194885
[TBL] [Abstract][Full Text] [Related]
3. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature.
Hurst EA; Mauro T
Arch Dermatol; 2005 Jul; 141(7):865-8. PubMed ID: 16027302
[TBL] [Abstract][Full Text] [Related]
4. [Sarcoidosis following combined ribavirin and interferon therapy: a case report and review of the literature].
Alfageme Michavila I; Merino Sánchez M; Pérez Ronchel J; Lara Lara I; Suárez García E; López Garrido J
Arch Bronconeumol; 2004 Jan; 40(1):45-9. PubMed ID: 14718122
[TBL] [Abstract][Full Text] [Related]
5. Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature.
Tahan V; Ozseker F; Guneylioglu D; Baran A; Ozaras R; Mert A; Ucisik AC; Cagatay T; Yilmazbayhan D; Senturk H
Dig Dis Sci; 2003 Jan; 48(1):169-73. PubMed ID: 12645805
[TBL] [Abstract][Full Text] [Related]
6. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
Hoffmann RM; Jung MC; Motz R; Gössl C; Emslander HP; Zachoval R; Pape GR
J Hepatol; 1998 Jun; 28(6):1058-63. PubMed ID: 9672184
[TBL] [Abstract][Full Text] [Related]
7. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases.
Gitlin N
Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):883-5. PubMed ID: 12172411
[TBL] [Abstract][Full Text] [Related]
8. [Sarcoïdose in patient with chronic hepatitis C treated with pegylated interferon].
Moudden MK; Ziadi T; Al Bouzidi A; Ouarssani A; Hadri L; El Baaj M
Rev Pneumol Clin; 2014 Dec; 70(6):362-5. PubMed ID: 25131364
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.
Lee SD; Yu ML; Cheng PN; Lai MY; Chao YC; Hwang SJ; Chang WY; Chang TT; Hsieh TY; Liu CJ; Chen DS
J Viral Hepat; 2005 May; 12(3):283-91. PubMed ID: 15850469
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary sarcoidosis associated with pegylated interferon in the treatment of chronic hepatitis C].
Ubiña-Aznar E; Fernández-Moreno N; Rivera-Irigoín R; Navarro-Jarabo JM; García-Fernández G; Pérez-Aisa A; Vera-Rivero F; Fernández-Pérez F; Moreno-Mejías P; Méndez-Sánchez I; de Sola-Earle C; Sánchez-Cantos A
Gastroenterol Hepatol; 2005 Oct; 28(8):450-2. PubMed ID: 16185580
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
Honsová E; Sticová E; Sperl J
Cesk Patol; 2007 Jan; 43(1):27-30. PubMed ID: 17370474
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary sarcoidosis during interferon therapy: a rare or underestimated event?
Salvio A; Mormile M; Giannattasio F; Varriale M; d'Errico T; Balzano B; Carratù P; Tufano G; Visconti M
Ann Ital Med Int; 2004; 19(1):58-62. PubMed ID: 15176710
[TBL] [Abstract][Full Text] [Related]
13. A levitating tattoo in a hepatitis C patient on treatment.
Atluri D; Iduru S; Veluru C; Mullen K
Liver Int; 2010 Apr; 30(4):583-4. PubMed ID: 20015152
[No Abstract] [Full Text] [Related]
14. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine.
Pérez-Alvarez R; Pérez-López R; Lombraña JL; Rodríguez M; Rodrigo L
J Viral Hepat; 2002 Jan; 9(1):75-9. PubMed ID: 11851906
[TBL] [Abstract][Full Text] [Related]
15. Interferon therapy: the other face of the medal.
Licata A; Craxì A
Ann Ital Med Int; 2004; 19(1):5-7. PubMed ID: 15176703
[No Abstract] [Full Text] [Related]
16. [Sarcoidosis during the treatment of hepatitis C by interferon-alpha and ribavirin: 2 cases].
Lévêque L; de Boulard A; Bielefeld P; Sgro C; Hillon P; Gabreau T; Champigneulle B; Makki H; Besancenot JF
Rev Med Interne; 2001 Dec; 22(12):1248-52. PubMed ID: 11794896
[TBL] [Abstract][Full Text] [Related]
17. Uterine sarcoidosis potentially associated with interferon-alpha use for chronic hepatitis C infection.
Tsiodras S; Drimala P; Stavreas N; Dachlythras M; Alamani AM; Naoum G
Obstet Gynecol; 2005 May; 105(5 Pt 2):1198-201. PubMed ID: 15863580
[TBL] [Abstract][Full Text] [Related]
18. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
19. Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C.
Taliani G; Biliotti E; Capanni M; Tozzi A; Bresci S; Pimpinelli N
J Chemother; 2005 Apr; 17(2):212-4. PubMed ID: 15920908
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.
el-Zayadi A; Selim O; Haddad S; Simmonds P; Hamdy H; Badran HM; Shawky S
Ital J Gastroenterol Hepatol; 1999; 31(6):472-5. PubMed ID: 10575565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
